Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
Yeo Jin Choi,1 Dae Jung Kim,2 Sooyoung Shin3,41Clinical Trial Center, Hallym University Hospital, Anyang, Republic of Korea; 2Department of Endocrinology and Metabolism, School of Medicine, Ajou University, Suwon, Republic of Korea; 3Department of Clinical Pharmacy, College of Pharmacy, Ajou Univers...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-08-01
|
| Series: | Cancer Management and Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/incident-cancer-risk-in-dipeptidyl-peptidase-4-inhibitor-treated-patie-peer-reviewed-article-CMAR |